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Abstract
Thyroid nodules are extremely common and the vast majority
are non-malignant; therefore the accurate discrimination of
a benign lesion from malignancy is challenging. Ultrasound
(US) characterisation has become the key component of many
thyroid nodule guidelines and is primarily based on the detec-
tion of key features by high-resolution US. The thyroid imager
should be familiar with the strengths and limitations of this
modality and understand the technical factors that create and
alter the imaging characteristics. Specific advances in high-
resolution US are discussed with reference to individual fea-
tures of thyroid cancer and benign disease. Potential roles for
three-dimensional thyroid ultrasound and computer-aided di-
agnosis are also considered. The second section provides an
overview of current evidence regarding thyroid ultrasound
elastography (USE). USE is a novel imaging technique that
quantifies tissue elasticity (stiffness) non-invasively and has
potential utility because cancers cause tissue stiffening. In
recent years, there has been much research into the value of
thyroid USE for distinguishing benign and malignant nodules.
Preliminary findings from multiple pilot studies and meta-
analyses are promising and suggest that USE can augment
the anatomical detail provided by high-resolution US. How-
ever, a definite role remains controversial and is discussed.
Teaching points
• High-resolution US characterises thyroid nodules by dem-
onstration of specific anatomical features
• Technical advances heavily influence the key US features of
thyroid nodules
• Most papillary carcinomas appear stiffer than benign thy-
roid nodules on US elastography (USE)
• Thyroid USE is controversial because of variation in the
reported accuracies for malignancy
• Combined grey-scale US/USE may lower the FNAC rate in
benign nodules
Keywords Thyroid nodules . Thyroid cancer . Ultrasound .
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Introduction
Ultrasound (US) examination of the neck is a commonly per-
formed investigation and thyroid nodules are a highly preva-
lent finding. As the vast majority of nodules are non-malig-
nant, the accurate discrimination of a benign from cancerous
lesion is an important and challenging feature of thyroid US.
Whilst single US features remain of limited accuracy, constel-
lations of findings enable thyroid nodules to be accurately
stratified on a ‘risk-of-malignancy’ basis and form the basis
of several guidelines [1, 2]. Imaging features that confer a high
positive predictive value and specificity for malignancy are
valuable as they enable suspicious lesions to be identified
and targeted for pathological analysis (typically fine-needle
aspiration cytology, FNAC). The ubiquitous nature of thyroid
nodules and the limitations of cytology mean that the confi-
dent identification of benign nodules is also important. US
characteristics that carry a high negative predictive value for
malignancy enable an evidence-based decision not to investi-
gate further, allowing unnecessary FNAC and/or surgery to be
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avoided in a very large population. Many of these key thyroid
nodule features are heavily dependent on recent advances in
high-resolution ultrasound technology and are therefore al-
tered and influenced by US machine settings. In an era of
wider US use by different groups (e.g., endocrinologists, sur-
geons), the high-resolution features of thyroid disease—and
the technical factors, which create and alter these valuable
signs—must be familiar to the operator.
US elastography (USE) is a recent technological ad-
vance that measures tissue elasticity or stiffness properties
objectively and has been available in recent years on
many state-of-the-art clinical US machines. USE is clas-
sified as diagnostic ultrasound and is safe, non-invasive
and requires no costly consumables. Importantly, USE can
be performed in real-time alongside conventional sonog-
raphy, providing objective stiffness data that can be used
to influence clinical decisions during US examinations.
The clinical potential of USE relies on the same principles
as clinical palpation, namely that processes such as ma-
lignancy and fibrosis alter elasticity. Numerous clinical
applications of USE are under investigation at different
body sites. To date, over 100 preliminary studies on
USE for thyroid nodules for malignancy have been pub-
lished, with promising but controversial results, as will be
discussed.
This article will focus on two aspects of thyroid ultrasound:
first, technical advances in high-resolution US are discussed
with relevance to specific features of thyroid cancer, benign
disease and emerging developments. The second part of the
article provides a concise overview of the current role of
elastography and how elasticity imaging may supplement
high-resolution ultrasound in the pursuit of accurate thyroid
nodule assessment.
Advances in ultrasound image resolution
Thyroid nodule detection, margin delineation and size mea-
surement are heavily influenced by spatial resolution. Modern
high-frequency US probes utilise piezoelectric material that
resonate at higher frequencies and across wider bandwidths
(i.e., PureWaveTM, Philips) than older crystals. Improving the
source piezoelectric material enables the effective bandwidth
of the probe to be used more efficiently and uniformly than
was previously possible [3]. The resulting improvements in
spatial resolution are particularly beneficial in superficial
structures such as the thyroid. In addition, probes now contain
higher numbers of elements (e.g., high-density 18 L6, Sie-
mens ACUSON) facilitating more versatile beam forming
and providing the basis for increasingly advanced compound
imaging. Spatial compounding refers to composite images
created by insonations from transmitted pulses at multiple
different angles to the probe surface (Fig. 1) whilst frequency
compounding generates images based on a range of frequen-
cies across the probe bandwidth [4]. The two techniques are
often used simultaneously, producing higher resolution im-
ages with smooth tissue planes and increased signal-to-noise
ratios. Traditionally, these methods of improving spatial reso-
lution have come at a cost: a reduced frame rate (temporal
resolution) due to the conventional ultrasound transmit-
receive cycle. The newest technical developments aim to min-
imise this limitation; an example is the use of precision beam-
forming, multi-line transmission and parallel processing
(nSIGHTTM, Philips) to combine high spatial and temporal
resolution. As a final consideration, the availability of high-
definition, multi-position monitors enables the information
acquired and processed by the transducer to be clearly
displayed for interpretation.
Contrast resolution settings are the primary factors that
influence the assessment of nodule consistency, reflectivity
and the detection of echogenic foci due to calcium or colloid.
Whilst broader bandwidths allow improved beam penetration
in the neck, the majority of advances in this aspect of thyroid
ultrasound relate to how the echoes are received and processed
rather than the pulse transmission. Signal processing (also
known as speckle reduction) techniques are designed to inter-
rogate lines of echoes obtained on each frame and improve the
signal-to-noise ratio by pattern recognition [5]. For example,
an anechoic area containing background noise will be
recognised as a cystic structure and the abrupt change in ech-
oes around the margins of this target then recognised as the
cyst/vessel wall (e.g., Precision ImagingTM, Toshiba). This
process of removing unwanted noise leads to images that look
sharper because of the improved signal-to-noise ratio and em-
phasise cystic vs. solid consistency. The dynamic range and
grey-scale map are inherently linked but different aspects of
high-resolution ultrasound. The dynamic range controls the
range of grey (or the preferred colour tint) that is available to
display echo intensity, whilst the grey-scale map allocates
which parts of this spectrum are used to represent the echo
signals received [6]. Tissue harmonic imaging (THI)—an
established technique for improving image contrast at other
body sites—has recently become more relevant to high-
frequency ultrasound. As the basis of this technique is to re-
ceive a signal from the second harmonic frequency of the
probe’s transmit pulse (i.e., twice the probe transmit frequen-
cy), its use in superficial structures has been limited [7]. How-
ever, the advent of wider bandwidths and more sophisticated
receive technology means that THI is increasingly available to
use with high-frequency probes (e.g., Hitachi High definition
dynamic THI) resulting in further removal of clutter/noise and
improved tissue contrast. Basic ultrasound settings (focal
zones, time gain control, etc.) also affect image quality but
are not covered in this article.
The following key thyroid nodule characteristics are heavi-
ly influenced by these improvements in image resolution.
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Whilst multiple factors contribute to the assessment of these
signs, the predominant technical consideration is discussed for
each in turn:
& Margin delineation:
An abnormal thyroid nodule margin is a recognised feature
of thyroid malignancy. Assessment of the nodule edge has
previously been binary; the margin is either well or poorly
defined. A poorly defined/irregular nodule margin conferred
87% specificity for malignancy in a study population of 1,108
thyroid nodules but with a very low sensitivity of 39 % [8].
Whilst operator experience is an important factor in edge de-
lineation, the machine settings heavily influence this assess-
ment and create a challenge for standardised reporting be-
tween observers using different equipment. The probe fre-
quency, bandwidth and use of compound imaging are the
key technical aspects to consider here (Fig. 2), delivering im-
proved signal-to-noise ratios for the operator to delineate the
nodule from the surrounding thyroid parenchyma and adja-
cent structures. More recently, the concept of a ‘spiculated’
margin (Fig. 3) has been introduced to describe the finding of
a distinctly infiltrative nodule edge (as separate from the
broader ‘poorly defined’ category) with 92 % specificity and
81% positive predictive value in a comprehensive review of B
mode ultrasound findings [9]. The ability to detect margin
spiculation is a consequence of higher spatial and temporal
resolution and it therefore follows that the reliable detection
of this useful characteristic requires access to the advances in
the above-described ultrasound technology. Understanding
the close relationship of technology to sonographic interpre-
tation is particularly important because—of all the individual
thyroid nodule features—margin delineation has the poorest
inter-observer agreement [10]. The multiple technical factors
are likely to contribute to this variability and are particularly
relevant when patients undergo thyroid ultrasound at different
centres with varying ultrasound probe and software settings.
& Smaller nodule detection:
The rising incidence of thyroid cancer across many coun-
tries is almost entirely attributable to small (<2 cm) papillary
carcinoma [11]. Multiple factors have contributed to the phe-
nomenon of the clinically occult papillary thyroid cancer; in-
cidental detection on other imaging modalities, patient aware-
ness and access to health care amongst others. The ability to
visualise and identify suspicious features within these small
nodules (e.g., margin irregularity, microcalcification) is, how-
ever, a consequence of the advances in high-resolution ultra-
sound. Sub-centimetre nodules can be identified,
characterised and targeted for FNA if appropriate (Fig. 4).
This has created difficulty for guidelines that have been pri-
marily based on nodule size (i.e., the Society of Radiologists
in Ultrasound [12]), particularly given the increasing under-
standing that size alone is not an accurate predictor of malig-
nancy [13].Moreover, improved resolution enables better nee-
dle tip visualisation during US-guided FNA/biopsy and
obtaining an adequate cytological specimen from very small
(i.e., 5 mm) nodules is feasible, although lower adequacy rates
are reported from FNA of these smallest lesions [13]. The
clinical benefit of confirming malignancy in this setting is
controversial—and beyond the scope of this article—as the
prognosis for small papillary thyroid cancers is generally ex-
cellent, prompting the proposal of a separate nomenclature,
‘papillary lesion of indolent course’ [11]. The reality for the
thyroid US operator at present is that he or she will regularly
Fig. 1 High-resolution images
through a phantom using
perpendicular (a) and spatial
compounding (b) beams.
Courtesy of Toshiba
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be confronted with small but suspicious incidental nodules
that would previously have remained undetected.
& Nodule consistency
The majority of malignant nodules are solid, but the ma-
jority of solid nodules are benign. Whilst solid nodule consis-
tency is of very limited value in identifying thyroid cancer, the
finding of microcystic aggregates creating a ‘spongiform’ ap-
pearance is an extremely strong predictor of benignity (99.7 %
negative predictive value) [9]. As purely cystic nodules are
also confidently benign, the ability to accurately detect cystic
spaces within a nodule is an important facet of the ultrasound
assessment. Spongiform areas can be detected with the aid of
compound imaging whilst speckle reduction software
removes the noise/clutter from the small cystic spaces. With-
out the use of these techniques, speckle artefact and blurred
septations can mimic solid components and lead to unneces-
sary investigation of benign nodules.
& Nodule reflectivity
Most thyroid cancers are hypoechoic compared to the
background parenchyma. Unfortunately, this finding is non-
specific as benign nodules can also be hyporeflective and the
comparison with ‘normal’ thyroid may be hampered by back-
ground nodularity or thyroiditis. By comparison, marked
hypoechogenicity—defined as ‘less reflective than adjacent
strap muscle’—is a specific malignant finding with an odds
ratio of 8.46 in a retrospective study of 849 thyroid nodules
[14]. Although this feature is only seen in the minority of
cancers, its recognition makes a benign nodule unlikely and
will typically initiate further investigation with FNAC
(Fig. 5). Dynamic range and grey-scale map settings predom-
inantly control image contrast whilst the use of harmonic im-
aging will further emphasise differences in reflectivity. A nar-
row dynamic range will increase the contrast between adjacent
structures by utilising fewer shades of grey to display the echo
signal intensity. Whilst these settings are typically configured
within manufacturer presets, they can be altered easily on
most ultrasound platforms and should ideally be customised
to the user’s preferences. The clinical value of marked
hypoechogenicity as a specific sign of thyroid cancer empha-
sises the importance of being familiar with one’s ownmachine
settings.
& Echogenic foci—colloid vs. calcium
In addition to the choice of the dynamic range and grey-
scale map, signal processing techniques help to identify small
hyperechoic foci. Bright spots that show a ‘ring down’ or
‘comet tail’ artefact are a very helpful finding; they represent
Fig. 2 Transverse images of a
predominantly cystic left lobe
nodule obtained without (left) and
with (right) spatial and frequency
compounding software. Note the
improved delineation of the
thyroid (arrow) and cystic nodule
(block arrow) margins
Fig. 3 Longitudinal image of a hypoechoic nodule with a spiculated
margin (arrows) and anterior capsular breach on high-resolution
ultrasound. The lesion was confirmed as a papillary thyroid carcinoma
on surgical resection
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foci of inspissated colloid and are a feature of benign nodules.
Conversely, the presence of sub-millimetre, highly reflective
foci with or without acoustic shadowing represents
microcalcification—a specific feature of differentiated thyroid
malignancy [15]. The depiction of the comet tail artefact is
therefore crucially important to confirm the benign nature of
an echogenic focus. As would be expected, signal processing
emphasises the bright focus and can help to make the comet
tail more conspicuous to the operator (Fig. 6).
Traditionally, the detection of microcalcification (usually
due to small psammoma bodies within papillary thyroid
cancer) was made easier by the associated acoustic shadow
artefact created by reflection of the perpendicular ultrasound
beam [16]. In high-resolution ultrasound, the use of spatial
compounding means that the signal can be received from tis-
sue deep to calcific foci (Fig. 7) and this artefact is often
diminished or lost in the thyroid. This unwanted consequence
of modern technology can be overridden by deactivating spa-
tial compounding and allowing acoustic shadows to emerge—
if the operator understands the significance of the artefact and
its causation.
An alternative method of highlighting microcalcification
within thyroid nodules is to alter the grey-scale map, dynamic
range and speckle reduction combination (Fig. 8). Boosting
the brightness of the signal received from calcific spots rela-
tive to normal parenchyma increases the detection and has
been investigated in breast ultrasound (where the identifica-
tion of microcalcification also carries significant clinical val-
ue) [17]. A novel modified grey-scale map/image tint combi-
nation to detect microcalcification (MicroPure Imaging,
Toshiba) has been recently reported in thyroid nodules [18].
Emerging uses of thyroid ultrasound
The technological progress of B mode US enables the thyroid
gland to be assessed in more anatomic detail than ever before,
characterising lesions by a matrix of structural features. Build-
ing on these advances, the value of three-dimensional US in
thyroid nodule assessment has recently been considered
[19–21]. Initial studies have focussed on two aspects: the abil-
ity to more accurately assess the key B mode features (e.g.,
nodule margin) and the potential to uncover independent pre-
dictors of malignancy from 3D data sets. Whilst 3D US is not
widely used in the neck at present, recent developments in this
Fig. 4 Longitudinal image of a
1.5-cm nodule (block arrow)
detected incidentally on cervical
spine MRI. This nodule is
spongiform and appears
confidently benign. However, a
0.6-cm ill-defined nodule
alongside (arrow) is hypoechoic
and contains microcalcification—
FNAwas performed from this
nodule and confirmed papillary
thyroid carcinoma
*
Fig. 5 Transverse image of the right thyroid lobe showing a nodule
(arrow) of slightly lower reflectivity than the adjacent strap muscle (*),
i.e., ‘markedly hypoechoic’. A pT1b infiltrative, classical papillary
thyroid carcinoma was found on surgical resection
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area suggest the potential to address persisting challenges of
thyroid imaging.
In a prospective study of 91 thyroid nodules, the interob-
server agreement for specific characteristics (e.g., shape, mar-
gin) was better for 3D than 2D US. Although intra-observer
agreement remained suboptimal, there was significantly stron-
ger agreement between users for suspicion of malignancy after
off-line review of the static 3D images [21]. National guide-
lines are increasingly based on standardised classification of
malignant risk [1, 22] (as opposed to subjective assessment by
experienced individuals); therefore reducing inter-observer
variation is particularly relevant [1, 21, 22].
In a retrospective study of 71 thyroid nodules, 3D ultra-
sound data were analysed using multiplanar reformatted
(MPR) images and a thin-slice volume-rendered technique
[19]. The MPR data found that poorly defined 3D nodule
margins were associated with malignancy but also described
two novel, independent 3D predictors of malignancy: a
lobulated nodule shape in the C-plane (coronal) and altered
central 3D vascularity. The smooth surface, thin-slice volume-
rendering algorithm created images with higher contrast and
reduced noise: a new layer of post processing to compare with
existing 2D techniques. The shift in emphasis from real-time
image interpretation to volume acquisition with subsequent
processing and multiplanar viewing also offers potentially
more detailed data analysis. A study of 20 thyroid nodules
assessed 3D high-resolution ultrasound data with a
computer-aided diagnostics (CAD) software programme
[20]. The authors found that CAD-detected specific 3D tex-
tural features could be identified and combined as an accurate
discriminator of benign and malignant nodules, creating auto-
mated malignant risk stratification (‘Thyroid Malignancy In-
dex’). Such an approach would represent a paradigm shift in
practice for most thyroid imagers but the potential for accurate
objective data to support an operator’s skill and experience is
attractive.
Fig. 6 A cystic nodule without
(left) and with (right) signal
processing software active. Note
the increased conspicuity of the
comet tail artefact (arrow) on the
active image. Images courtesy of
Dr S.T. Elliott
Fig. 7 Longitudinal images of
carotid bulb atheroma without
(left) and with (right) spatial
compounding active. Note the
diminished acoustic shadow with
spatial compounding (arrows)
despite the overlying coarse
calcification. Images courtesy of
Dr S.T. Elliott
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Regarding contrast-enhanced ultrasound (CEUS), a small
number of studies have documented the feasibility and diag-
nostic accuracy of assessing thyroid nodule enhancement fol-
lowing intravenous microbubble contrast, using low mechan-
ical index (MI) settings [23, 24]. Recognisable quantitative
patterns of perfusion have been identified to construct CEUS
malignant risk stratification with 76.9 % sensitivity and
84.8 % specificity in a study of 42 patients [24]. These find-
ings suggest a potential role for CEUS as a diagnostic adjunct
to B mode US but the technique is more invasive and time-
consuming than standard ultrasound and, at present, the spe-
cific clinical utility is unclear.
US elastography (USE)
& Basic principles
Elasticity refers to the tendency of a tissue to undergo a
reversible deformation and is quantified by Young’s modulus
(E) in kiloPascals (kPa), which equals the ratio of an applied
stress to the induced strain (displacement/original length) [25,
26]. USE technologies either estimate elasticity or a surrogate
parameter such as strain from US signals acquired during a
mild tissue deformation, which can be displayed two-
dimensionally as elastograms. A range of proprietary USE
technologies is available commercially, which can be divided
into strain elastography (strain USE) and shear wave
elastography (SWE) based on their underlying physics.
In strain USE, also known as quasi-static elastography,
compression elastography and real-time elastography (RTE),
a mechanical stress is used to deform the tissue of interest and
returning US signals are software processed to generate dy-
namic elastograms of relative tissue strain. In the thyroid, ei-
ther the operator applies freehand compression to gently com-
press and decompress a nodule axially under the transducer, or
alternatively nodules in the lateral lobe may be compressed
solely by transmitted pulsations from the adjacent common
carotid artery (Fig. 9). Elastograms are displayed as an opacity
layer over and beside corresponding grey-scale US images
(split screen mode) using a chromatic scale that varies be-
tween manufacturers. Operators performing freehand com-
pression must use a precise manual technique to generate
high-quality elastograms, which can be optimised by referring
to compression quality scales that are automatically computed
and displayed in real time (Fig. 10). Strain elastograms are
either interpreted qualitatively, based on visual grading of
the proportion and distribution of different colours within
the nodule (Fig. 11), or semi-quantitatively using strain ratios
(computed from regions of interest (ROIs) placed in the nod-
ule and adjacent thyroid parenchyma) or other indices such as
strain heterogeneity. Presently, there is no agreement on an
optimal qualitative scoring system although many investiga-
tors have used 4- or 5-point scales whereby higher
elastography scores (ES) signify higher nodule stiffness [27,
28]. Strain USE is unsuitable for nodules without sufficient
reference tissue in the elastogram, which basically excludes
single or conglomerate nodules exceeding ~3 cm diameter.
SWE technologies applicable to thyroid imaging use high-
ly focused ultrasound impulses to induce minuscule localised
lateral displacements at different locations within the tissue
called shear waves, followed by ultrasound detection impulses
to track shear wave propagations [25]. SWE is also known as
acoustic radiation force impulse imaging (ARFI). Shear waves
travel faster in stiffer tissues, whereby shear wave velocity
(SWV) is directly proportional to the square root of Young’s
modulus. Unlike strain USE, SWE output is quantitative;
expressed as SWV (m/s) or estimated tissue stiffness (kPa).
Due to differences in proprietary SWE technologies between
manufacturers, SWE outputs are varied. These include static
colour-coded elastograms termed 2D SWE or a single numer-
ical estimate for an ROI of fixed dimensions (~5 × 6 mm)
Fig. 8 Transverse images of a 1-cm thyroid isthmus nodule using
standard thyroid ultrasound (left) and modified grey-scale map/dynamic
range presets (right). Macro- (block arrow) and microcalcifications
(arrow) are much more conspicuous with the modified preset, originally
designed to detect calcification in breast lesions. A follicular variant
papillary thyroid carcinoma containing dystrophic and psammomatoid
calcification was confirmed on resection
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termed point SWE (pSWE). At least one commercial SWE
system produces elastograms in real time, fromwhich SWVor
Young’s modulus estimates can be computed for ROIs select-
ed by the operator (Fig. 12).
& Accuracy of USE for malignancy
Presently about 80 studies of strain USE and 20 studies of
SWE have been published for thyroid malignancy since 2005
[29–35]. Most are single-institutional series with heteroge-
neous designs, comprising around 100 nodules selected for
FNAC or surgery because of suspicious or equivocal sono-
graphic features, suspicious or malignant cytology or nodules
within a compressive goitre. Most studies have also variably
excluded nodules containing coarse macro-calcifications, sub-
stantial cystic areas or those within a diffuse thyroiditis as
early evidence suggested that USE is suboptimal in these
cases. Due to this selection bias, a much higher proportion
of nodules in these studies is malignant (~25 %) than in an
unselected population (~5 %) and most are papillary carcino-
mas (~90 %); thus published discriminatory performance data
actually refer to this histological type [29–35].
Promisingly, most studies indicate that papillary cancers
have significantly higher stiffness indices on USE compared
to benign nodules although there is some overlap (Figs. 11,
12, 13 and 14). Furthermore, most evidence suggests that USE
has a superior overall accuracy compared to single or multiple
conventional US criteria. Multiple meta-analyses confirm the-
se findings [29–35] including the largest to date, which reports
a pooled mean sensitivity, specificity, PPV, NPVand accuracy
of 87, 80, 47, 97 and 81 % for strain USE using freehand
compression (N=4,926); 87, 80, 52, 100 and 82 % for strain
USE using carotid artery pulsation (N=241) and 86, 89, 60, 97
and 89 % for SWE [34]. From the pooled data, SWE has
higher accuracy compared to strain USE, while performing
strain USE using carotid arterial pulsations is slightly superior
Fig. 10 Longitudinal strain USE
and B mode US of a papillary
carcinoma (white arrow). Colour
scale in the top left shows stiff,
intermediate and soft areas as
blue, green and red, respectively.
The nodule appears mostly blue
suggesting a firm nodule.
Compression quality feedback
scales are displayed in real time to
assist operators in optimising their
technique (arrowheads)
Fig. 9 Schematic illustration of
(a) strain USE and (b) SWE for a
hard (red) and soft (green)
nodule. In strain USE, tissues are
deformed mechanically by the
operator via motion of the
transducer or by an external
source. Relative displacement
(strain) is greater in soft
compared to stiff tissues. In SWE,
focused acoustic impulses from
the transducer induce laterally
propagating shear waves, whose
velocities are higher in stiffer
tissues. Tissue displacements in
both techniques are tracked by
ultrasound detection impulses
(not shown)
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diagnostically compared to freehand compression. The pre-
cise cause for the high stiffness of papillary cancers needs to
be clarified but probably reflects intense tumour fibrosis, with
or without calcifications, which is characteristic of this
Fig. 12 Transverse and longitudinal SWE with B mode US image of a
hyperplastic nodule (left) and of a papillary carcinoma (right)
respectively. The SWE elastogram chromatic scale ranges from blue to
red, denoting soft to stiff (0 kPa to 180 kPa). Quantitative measurements
are acquired for operator-placed ROIs. The benign nodule has a
maximum SWE stiffness of 14.7 kPa whereas the cancer has a
maximum stiffness of 227.6 kPa
Fig. 11 Strain USE scoring
system showing a typical 4-point
qualitative scoring system. The
chromatic scale in this machine,
shown on the right side of each
elastogram, differs from that used
on the machine used to generate
Fig. 10, with red and purple
colours denoting high and low
relative stiffness respectively. The
examples shown for ES1 and ES2
were a collapsed haemorrhagic
cystic nodule and benign
hyperplastic nodule respectively,
and ES3 and ES4 were papillary
carcinomas. These examples
would be classified correctly
using most scoring systems
published to date, which
generally apply a strain USE
threshold of ES3 or greater to
predict malignancy
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histology although not always present (~80 %) [36]. Indeed,
anecdotal examples of high USE indices are reported for be-
nign nodules containing dense fibrotic foci and calcifications
histologically as well as low USE indices in some papillary
and follicular cancers lacking substantial fibrosis [37].
Despite the mostly promising data described above, a role
of USE in thyroid nodules is controversial because of a
marked heterogeneity in published accuracy results including
optimised cutoffs for malignancy, and importantly a small but
significant number of recent studies have markedly subopti-
mal findings [38–43]. One study assessed 703 nodules by
conventional US and qualitative strain USE (31% cancer)
and reported a suboptimal diagnostic performance for USE
(65% sensitivity, 58% specificity and 61% accuracy) in com-
parison with conventional US (92% sensitivity, 67% specific-
ity and 74% accuracy) or combined US/USE [42]. Even
among studies of strain elastography using semi-quantitative
SRs, there is a wide dispersion in mean SRs of benign and
malignant nodules as well as optimal cutoffs for malignancy
[44–49]. Discrepant results have also been documented for
quantitative USE. For example, optimised cutoffs for malig-
nancy in studies using an identical SWE technology range
between 39.3 kPa and 66 kPa, and corresponding diagnostic
performances range between 52.9 % sensitivity, 77.8 % spec-
ificity to 85.2 % sensitivity, 93.9 % specificity [50, 51]. The
reasons for the wide variation in results are unclear at present.
& Potential role of use in clinical practice
Approximately a dozen studies have evaluated the com-
bined performance of USE with US (US/USE) [40, 42,
51–59] and nearly one half of these suggest that US/USE
can achieve both excellent sensitivity and negative predictive
values (NPV) for malignancy (92–100 %), surpassing con-
ventional US [42, 52–56] (Table 1). One study of 498 nodules
reported 97 % sensitivity and 97 % NPV for combined US/
Fig. 13 Transverse strain USE with B mode US images of a papillary
carcinoma (left) and hyperplastic nodule (right). Using the qualitative
scoring scale from Fig. 11, the cancer appears soft (ES1) whereas the
hyperplastic nodule appears mostly stiff (ES3). These would be false
negative and false positive for malignancy using most scoring systems
published to date, which apply a strain USE threshold of ES3 or greater to
predict malignancy
Fig. 14 Transverse and longitudinal SWE with B mode US images of a
papillary carcinoma (left) and a hyperplastic nodule (right) respectively. The
SWE elastogram chromatic scale ranges from blue to red, denoting soft to
stiff (0 kPa to 180 kPa). The cancer appears uniformly soft with a maximum
SWE stiffness of 33.6 kPa whereas the hyperplastic nodule appears
heterogeneously stiff with a maximum SWE stiffness of 84.0 kPa. These
would be false negative and false positive for malignancy respectively using
any recently published SWE cutoff (cutoffs range between 39.3–66 kPa)
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USE compared to 85 % sensitivity and 91 % NPV for con-
ventional US alone [54]. This is an important finding as it
suggests that clinicians may be able to use USE as an ancillary
technique to identify nodules with a very low risk of malig-
nancy, which may be placed under observation rather than
undergo invasive investigations including FNAC or surgery.
Indeed, another study that evaluated 991 nodules using both
strain ratios and conventional US within a standardised clas-
sification system (US-TIRADS) also documented high sensi-
tivity (98.5 %) and NPV (99.8 %) for combined US-TIRADS/
USE and importantly estimated that FNAC could be reduced
by 34% using this combined approach [52]. In this respect, the
additional value of USE is likely to be greatest for nodules that
are indeterminate on conventional US in terms of displaying
one or two mildly suspicious features of malignancy, which
would all undergo FNAC under the current guidelines. This
probably includes nodules classified as TIRADS 3 Bprobably
benign^ and possibly TIRADS 4A Blow suspicion of
malignancy ,^ which collectively comprise approximately
80% of FNACs and of which 90 % are ultimately benign
[60]. USE is unlikely to be useful in terms of altering the
clinical decision of whether to perform FNAC for nodules that
are already very suspicious for malignancy or completely be-
nign on conventional US.
Another potential role for USE is for nodules with non-
diagnostic or indeterminate cytological results on FNAC
(e.g., cellular atypia of indeterminate significance), which af-
fects approximately 30% of FNACs [61–63]. A substantial
proportion of these nodules undergo hemi-thyroidectomy for
a definitive diagnosis because repeat FNACs are non-
diagnostic or because of limitations in cytological diagnosis
of follicular lesions, although 75–80% of these are ultimately
non-neoplastic [61, 62, 64]. Encouragingly several reports
indicate that USE or combined US/USE can attain high NPVs
for malignancy in this group (95–100 % NPV) [56, 59, 65,
66], although one study has documented the opposite findings
(50% NPV) [39]. If these positive findings can be validated in
larger studies, USE could lower the number of hemi-
thyroidectomies performed in this subgroup.
& Potential limitations of USE
Unfortunately, follicular carcinomas appear to have low
mean USE indices that overlap substantially with benign hy-
perplastic nodules and follicular adenomas [33]. This is dis-
appointing given the challenges in pre-surgical diagnosis of
follicular lesions but unsurprising given their histological sim-
ilarities [67]. Sparse data also suggest that USE is suboptimal
for detecting medullary thyroid carcinomas [68]. Macro-
calcifications are a confounding factor for USE as they in-
crease mean stiffness estimates of ROIs that include them
and are common in both benign and malignant pathologies
[69, 70]. However, some evidence suggests that novel semi-
quantitative USE indices such as strain heterogeneity may be
diagnostically accurate in partially calcified nodules [70]. Pre-
dominantly cystic nodules are unsuitable for strain USE but
not SWE for technical reasons related to uneven stress trans-
mission in the former [28, 41]. Graves disease, Hashimoto’s
thyroiditis and subacute thyroiditis can cause parenchymal
stiffening [71–73] and therefore would be expected to lower
the accuracy of strain USE for malignancy, although some
evidence suggests that strain USE is still accurate for nodules
in a background thyroiditis [66, 74]. As SWE does not require
a reference tissue, nodule stiffness estimated by SWE is prob-
ably not altered significantly by a background thyroiditis [69,
75]. The influence of nodule dimensions on USE indices is
Table 1 Diagnostic performances of conventional US and a combination of conventional US and USE for diagnosing thyroid malignancy
First author, year (citation) n (% malignant) Type Sensitivity (%) Specificity (%) Accuracy (%) PPV (%) NPV (%)
US US/USE US US/USE US US/USE US US/USE US US/USE
Sebag, 2010 [46] 146 (19.9) SWE 51.9 81.5 97 97 ND ND 82.4 88 88.1 95
Trimboli, 2012 [49] 498 (25.3) SE 85 97 54 34 62 50 38 33 91 97
Ragazzoni, 2012 [52] 132 (30.3) SE 70 85 92.4 83.7 85.6 84.1 80 69.4 87.6 92.8
Cappelli, 2012 [51] 159 (9.4) SE 80 100 75 70.8 75.4 73.6 25 26.3 97.2 100
Moon, 2012 [37] 703 (30.8) SE 91.7 92.2 66.7 65 74.4 73.4 55.1 54.1 94.7 94.9
Unluturk, 2012 [35] 237 (24.5) SE 69 41 85 93 81 81 60 67 89 83
Veyrieres, 2012 [50] 297 (11.8) SWE 77.1 97.1 58 55.3 ND ND 19.7 22.5 95 99.3
Shweel, 2013 [48] 66 (24.2) SE 92 95.4 72.9 94.8 60.1 95.2 95 82.3 63.1 98.8
Russ, 2013 [47] 991 (6.7) SE 95.7 98.5 61 44.7 62 48.3 ND ND 99.7 99.8
Garino, 2014 [54] 108 (30.6) SE 61 88 83 77 76 81 61 63 83 94
Liu, 2014 [53] 331 (30.5) SWE 76.2 87.1 83 73.9 81 78 66.4 59.5 88.8 92.9
Only published studies with both documented sensitivity and NPVresults are shown, and those with high sensitivities and NPVs (>95%) are indicated in
bold.US conventional US, PPV positive predictive value,NPV negative predictive value,US/USE combined conventional US and USE, SE strain USE,
SWE shear wave elastography, ND not documented
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controversial although USE appears to have similar diagnostic
performances for nodules ranging between 1 and 3 cm in
diameter. Some evidence indicates that USE indices and diag-
nostic accuracies are reduced in infra-centimetric nodules, al-
though many reports have found USE still to be highly accu-
rate in this subgroup [58, 70, 76, 77].
& Practical aspects and operator dependence of USE
USE is a dynamic technique with fluctuating elastographic
appearances due to its intrinsic sensitivity to miniscule dis-
placements that are continually occurring under physiological
conditions. Various components of USE acquisition and inter-
pretation are operator dependent including freehand compres-
sion for strain USE, selection of imaging planes through nod-
ules, selection of representative elastograms, qualitative scor-
ing of elastograms and placement of ROIs for (semi-)quanti-
tative measurements [78]. Strain USE using freehand com-
pression is highly dependent on an optimal axial compression
technique, which is hampered by competing non-axial mo-
tions (e.g., arterial pulsations and respiration) and the different
mobilities of tissues bordering the thyroid (e.g., immobile tra-
chea and mobile vessels). Carotid artery strain USE and SWE
circumvent this source of operator dependence. Nevertheless,
irrespective of the USE technology used, the operator influ-
ences the amount of resting pressure applied via a motionless
transducer, termed precompression, which in turn can alter
tissue stiffness [34]. This phenomenon reflects the fact the
Young’s modulus of biological tissues increases as strain is
increased, termed strain hardening, although this effect is
minimal for very small strains (<10 %). To mitigate this prob-
lem, USE should be performedwithminimal pressure applied,
which may be facilitated by maintaining an ample US gel
layer between the transducer and skin.
Various elastographic pitfalls and artefacts can occur in
thyroid USE, which need to be recognised and avoided. High
stiffness areas due to the stress concentration frequently de-
velop in the near field beneath the transducer including the
superficial aspect of some thyroid nodules, as well as at
boundaries of tissues with contrasting stiffness including the
margins of some nodules. Isthmic nodules are especially
prone to stress concentration effects because they tend to pro-
duce a focal skin bulge with uneven contact under the flat
transducer and be compressed directly against the unyielding
trachea. Other artefacts can also develop because of a subop-
timal compression technique, competing non-axial motions,
presence of cystic fluid and limitations of specific USE tech-
nologies (Fig. 15) [25, 79].
& Reproducibility of USE
Given the aforementioned sources of operator influence,
practical challenges and artefacts, establishing a high repro-
ducibility of thyroid USE is an important objective. An early
report of strain USE had disappointing reproducibility results
[80]; however most recent studies using newer USE technol-
ogies report substantial to excellent intra- and inter-observer
agreements [49, 55, 57, 79, 81–85]. Evidently, the inclusion of
compression quality assurance scales on strain USE systems
has had a positive influence on this aspect. Nevertheless, the
Fig. 15 Transverse SWE with B mode US images of two hyperplastic
nodules (left, right) showing elastographic artefacts. The SWE
elastogram chromatic scale ranges from blue to red, denoting soft to
stiff (0 kPa to 180 kPa). The left image highlights stress concentration
artefact in an isthmic nodule (white arrow), which occurs because the
nodule produces a convex bulge of the skin and is compressed against
the relatively hard trachea despite the use of an ample gel layer on the skin
surface. The right image shows vertically aligned bands of light blue
colour that traverse several anatomic structures (black arrows). These
are suggestive of technology-related push pulse artefacts corresponding
to peaks of shear waves induced at different lengths along the transducer.
Although they can be excluded from SWE measurements, they may be
inadvertently included if subtle
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fact remains that (semi-)quantitative USE indices have dif-
fered substantially between studies, including those evalu-
ating identical SWE technologies [35]. These discrepan-
cies may reflect sampling variations although their magni-
tude and pattern raises questions about additional mecha-
nisms, which in turn may influence reproducibility. One
postulation is that operators may be performing USE using
different degrees of precompression (Fig. 16) and may
even be unconsciously influenced by the nodule's grey-
scale appearances on the split-screen display (cognitive
bias) [86, 87]. At present, precompression cannot be mea-
sured or standardised reliably because pressure sensors are
not incorporated within transducers.
& Current and future directions of USE
According to recently published guidelines from the
European Federation of Societies of Ultrasound in Med-
icine and Biology (EFSUMB): Belastography is an addi-
tional tool for thyroid lesion differentiation^ and Bbased
on expert opinion, elastography may be used to guide
follow-up of lesions negative for malignancy at FNAC^
[88]. This cautious endorsement reflects the current con-
troversies in thyroid USE evidence. Clearly further re-
search is required including large multi-centre prospec-
tive trials of nodules with less pre-selection to evaluate
different nodule characteristics, uncommon pathologies
and reproducibility and ultimately determine how USE
can be integrated with conventional US into emerging
malignant risk classification systems (e.g., TIRADS). In
this respect, clarifying precisely which types of nodule
are unsuitable for thyroid USE will be critical to
optimising its accuracy.
Although controversial, USE shows promise as an adjunct
to conventional US for reliable identification of benignity in a
select group of nodules on the initial US examination as well
as those with non-diagnostic or indeterminate cytological re-
sults following FNAC. Even if these indications are validated
in future studies, several issues will still need to be addressed
before USE can be accepted widely in routine practice. USE
technologies should be robust and simple to apply by the
range of health care professionals who perform thyroid US
routinely. The specific strengths and limitations of each USE
technology including artefacts need to be catalogued system-
atically. While it is acknowledged that USE technologies are
proprietary and their outputs may not be interchangeable,
there should be greater standardisation of thyroid USE,
for example by unifying nodule-grading systems and
elastogram chromatic scales. Fortunately, USE technolo-
gies are continually improving including with respect to
measurement precision and quality assurance, which
should augment their diagnostic accuracies and reliabil-
ities. Ideally, with advances in CAD software, a nodule’s
grey scale and elastographic features could be analysed
automatically and converted into a single estimate of its
malignant risk. There are still some hurdles to overcome
although, at the current pace of promising research and
technological advances, USE may well become a valuable
complementary technique for evaluating thyroid nodules in
the near future.
Fig. 16 Longitudinal SWE with a B mode US image of a papillary
carcinoma under different degrees of precompression applied by the
operator. The SWE elastogram chromatic scale ranges from blue to red,
denoting soft to stiff (0 kPa to 180 kPa). The left image was acquired
using minimal precompression as evidenced by a preserved gel layer
between the skin and transducer (arrowheads), whereas the right image
was acquired using mild precompression as evidenced by the fact that the
gel interface layer is effaced and the nodule is closer to the skin surface.
The SWE stiffness of the cancer is much higher in the right image. This
deliberate example illustrates how variations in precompression can bias
USE results
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Conclusion
Innovative advances in high-resolution ultrasound now enable
detailed anatomical characterisation and accurate differentia-
tion of benign from malignant disease. Ultrasound has be-
come the core component of thyroid nodule guidelines, but
it is important that the key technological aspects of the mo-
dality are understood and that challenges and limitations re-
main with the technique. The large evidence base for ultra-
sound elastography indicates that the assessment of nodule
stiffness can improve the imaging evaluation of thyroid le-
sions and potentially avoids unnecessary FNAC/surgery for
benign nodules, particularly if integrated with US classifica-
tion. The potential for 3D and CEUS in thyroid nodule US has
not yet been realised, but the emergence of these novel ap-
proaches is an illustration of the huge strides that have been
made in the underlying ultrasound technology.
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